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Differential Expression of Lymphocyte Function-Associated Antigen 1 
(LFA-1) on Epidermotropic and Non-Epidermotropic T-Cell Clones 
To the Editor: 
The article "Differential Expression of Lymphocyte Function-As-
sociated Antigen 1 (LFA-1) on Epidermotropic and Non-Epider-
motropic T -Cell Clones" by Shiohara and co-workers [1] states that 
" the presence of high levels ofLFA-1 on T cells is absolutely neces-
sary for their epidermotropic migration." 
However, two parts of the results speak against this statement. 
First, there is one clone (82F12) that expresses high levels ofLFA-1 
without being epidermotropic. Second, even in those clones that 
have phorbol ester induced expression ofLFA-1, there is no change 
from a non-epidermotropic to an epidermotropic state. Thus it is 
more likely that LFA-1 is not the molecule primarily involved in 
this experimental epidermotropism. Interestingly, there is also no 
information concerning the expression of ICAM-1, the ligand of 
LFA-1 on the epidermis of the foot-pads which would allow the use 
of this receptor ligand pair in epidermotropism. This could have 
been simply tested by staining with monoclonal antibodies against 
murine ICAM-1. 
It rather seems likely that other receptor ligand pairs are relevant 
for the observation of the authors because normal epidermis ex-
presses a wide variety of ligands belonging to various adhesion mol-
ecule families that would permit the entrance of T cells into the 
epidermis [2] . 
Wolfram Sterry, M.D. 
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REPLY 
Dr. Sterry's comments regarding our recent paper [1] appear to 
contain a misapprehension of our observations and statement. Al-
though he did not mention the important findings of our previous 
study in his comments, we have clearly demonstrated that in vivo 
administration of monoclonal antibody (MoAb) to LFA-1 specifi-
cally blocks epidermotropic migration of cutaneous GVHD-pro-
ducing T cells and the subsequent destruction of the epidermis [2]. 
In addition, there is increasing experimental and clinical evidence to 
indicate that the receptor-ligand type interaction between LFA-1 on 
lymphocytes and ICAM-1 on keratinocytes serves a crucial role in 
adhesions of lymphocytes to epidermal keratinocytes [3,4]. Our 
findings that a close correlation between the density ofLFA-1 on T 
cells and the epidermotropic nature was observed in six clones of 
seven clones tested, together with the previous findings mentioned 
above, support the notion that the presence of high levels ofLFA-1 
on T cells is necessary for their epidermotropic migration. We do 
not state, however, that LFA-1 /1 CAM-1 interaction can be the only 
mechanism to explain the epidermotropism of certain T cells, be-
cause clone 82F12, despite high levels ofLFA-1 expression, is non-
epidermotropic. Thus, we are, of course, in agreement with the 
notion that adhesion molecules other than LFA-1 are also involved 
in epidermotropism of the T cells. However, his statement that 
adhesion molecules expressed by normal epidermis are involved in 
epidermotropism ofT cells seems unlikely. It does not make sense 
for the epidermis to normally express adhesion molecules that 
would allow the entry of leukocytes with ease. In order to protect 
the integrity of the epidermis from various unfavorable stimuli such 
as infection and trauma, this type of adhesion molecule should not 
be constitutively expressed, but be induced upon such stimuli on the 
keratinocytes. 
As mentioned briefly in the paper, it becomes clear that qualita-
tive, rather than quantitative, changes in LFA-1 expression are im-
portant for the regulation ofLFA-1- and ICAM-1-mediated leuko-
cyte adhesion [3,5]. Therefore, it is likely that up-regulation of 
LFA-1 with no increase in the avidity is not sufficient to trigger the 
epidermotropic migration. 
Because the mouse homologue of human ICAM-1 had not been 
identified at that time, and MoAb to human ICAM-1 such as RR1 /1 
did not cross-react to murine ICAM-1, it has remained to be deter-
mined whether ICAM-1 expression on keratinocytes is necessary 
for the epidermotropic migration of the T cells. Because a recent 
publication [6] showed that the murine lymphocyte activation anti-
gen MALA-2 is indistinguishable from human ICAM-1 in func-
tion, cellular distribution, and molecular properties, studies with 
the use of a rat MoAb to MALA-2 may provide direct evidence that 
LFA-1/ICAM-1 interaction is primarily involved in the epidermo-
tropic migration ofT cells. 
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